ProQR Therapeutics PRQR
NASDAQ PRQR
$1.40 +0.02 (+1.81%)
As of: Oct 21, 2026 · 11:14 AM EDT

ProQR Therapeutics (PRQR) Assets (2013 - 2026)

Updated

ProQR Therapeutics' Assets came in at $155.24 million for the quarter ended Jun 30, 2026, down 0.3% from $155.69 million a year earlier but up 33.9% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics' Assets was $127.39 million, down 29.9% from the prior year.

  • Assets carries a five-year compound annual growth rate of 2.5% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Assets was $181.79 million in the year ended Dec 31, 2024 (+21.9%), $149.15 million in the year ended Dec 31, 2023 (-17.4%), $180.56 million in the year ended Dec 31, 2022 (-27.2%) and $248.02 million in the year ended Dec 31, 2021 (+120.0%).
  • The five-year range for quarterly Assets is $115.94 million (the quarter ended Mar 31, 2026) to $239.75 million (the quarter ended Dec 31, 2021).
  • Year-over-year, Assets has declined for three consecutive quarters, with growth averaging 0.9% over the last eight quarters.
  • The fastest year-over-year change in Assets over five years came in the quarter ended Dec 31, 2021 (growth of 103.7%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 46.7%).
  • Business Quant data shows PRQR's Assets at $115.94 million (quarter ended Mar 31, 2026), $131.25 million (quarter ended Dec 31, 2025) and $145.37 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn 135.12 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 201.13 Bn
10 ProQR Therapeutics 148.52 Mn -312.14 Mn - 152.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 152.54 Mn
Mar 31, 2026 113.49 Mn
Dec 31, 2025 132.46 Mn
Sep 30, 2025 145.88 Mn
Jun 30, 2025 161.30 Mn
Mar 31, 2025 164.19 Mn
Dec 31, 2024 174.78 Mn
Sep 30, 2024 119.35 Mn
Jun 30, 2024 126.41 Mn
Mar 31, 2024 133.72 Mn
Dec 31, 2023 152.61 Mn
Sep 30, 2023 150.02 Mn
Jun 30, 2023 160.84 Mn
Mar 31, 2023 172.31 Mn
Dec 31, 2022 182.64 Mn
Sep 30, 2022 119.66 Mn
Jun 30, 2022 187.05 Mn
Mar 31, 2022 212.33 Mn
Dec 31, 2021 237.35 Mn
Sep 30, 2021 226.62 Mn
API Access

ProQR Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=PRQR&period=max&api_key=YOUR_API_KEY